{"": [65, 74, 0, 75, 1566, 0], "Statement of Significance": [1594, 2020, 0, 1567, 2020, 1], "INTRODUCTION": [2021, 6807, 0], "Database development": [6831, 7905, 0], "Analyses overview": [7906, 8865, 0], "Sequence alignment": [8866, 9464, 0], "Antibody interacting residues": [9465, 9925, 0], "MATERIALS AND METHODS": [6808, 9925, 1], "SARS-CoV-2 nucleotide mutations": [9935, 11497, 0], "SARS-CoV-2 amino acid mutations": [11498, 13676, 0], "Global distribution of RBD mutations": [13677, 14974, 0], "Mutations in antibody interacting residues found on the RBD": [14975, 15936, 0], "RESULTS": [9926, 15936, 1], "DISCUSSION": [15937, 19958, 0], "CONCLUSION": [19959, 20575, 0], "SUPPLEMENTARY DATA": [20576, 20644, 0], "DATA AVAILABILITY": [20645, 20805, 0], "CONFLICT OF INTEREST STATEMENT": [20806, 21011, 0], "Supplementary Material": [21012, 21222, 0]}